This is the first report showing that increased Brn-3b transcription factor may be important for controlling growth and behaviour of human ovarian cancer cells, particularly following treatment with common chemotherapeutic agents such as cisplatin and paclitaxel. This evidence concerns the gene POU4F2 and ovarian cancer.